Experimental evidence suggests that low p38 activity in the early stages of cancer may facilitate tumor formation and growth, while increased activation of this pathway in advanced tumor stages may be beneficial (Igea and Nebreda, 2015). Here, MAPK14 is linked to neoplasm.